REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 19 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 169,901 | $411,000 | 0.03% |
Benin Management CORP | 14,300 | $35,000 | 0.01% |
Northeast Financial Consultants Inc | 15,000 | $36,000 | 0.01% |
WEDBUSH SECURITIES INC | 25,500 | $62,000 | 0.01% |
Zurcher Kantonalbank (Zurich Cantonalbank) | 49,167 | $119,000 | 0.00% |
Renaissance Technologies | 344,299 | $833,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 8,238 | $20,000 | 0.00% |
NORTHERN TRUST CORP | 47,859 | $116,000 | 0.00% |
GROUP ONE TRADING, L.P. | 28 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 146,083 | $353,000 | 0.00% |